Molbio Diagnosti

  • Market Cap: Mid Cap
  • Industry: Healthcare Services
  • ISIN: INE869T01028
  • NSEID: MOLBIO
  • BSEID: 544866
INR
1,246.20
-64.2 (-4.9%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 70820

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Jun'25
Net Sales
408.38
560.62
99.71
Other Operating Income
0.00
0.00
0.00
Total Operating income
408.38
560.62
99.71
Raw Material Cost
131.47
241.98
77.94
Purchase of Finished goods
6.26
0.92
0.67
(Increase) / Decrease In Stocks
11.95
-7.51
-43.44
Employee Cost
45.92
45.92
28.18
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
112.19
120.59
51.61
Total Expenditure (Excl Depreciation)
307.79
401.90
114.96
Operating Profit (PBDIT) excl Other Income
100.59
158.72
-15.25
Other Income
3.10
4.79
0.76
Operating Profit (PBDIT)
103.69
163.51
-14.49
Interest
10.70
12.08
3.61
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
92.99
151.43
-18.10
Depreciation
17.08
19.60
12.32
Profit Before Tax
75.91
131.83
-31.28
Tax
23.17
36.00
-7.33
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
52.74
95.83
-23.09
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
52.74
95.83
-23.09
Share in Profit of Associates
0.00
0.00
-0.85
Minority Interest
-6.00
5.00
-0.23
Other related items
0.00
0.00
0.00
Consolidated Net Profit
58.75
90.83
-23.71
Equity Capital
11.28
11.28
2.26
Face Value
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.21
8.05
-10.49
Diluted Earnings per share
5.21
8.05
-2.1
Operating Profit Margin (Excl OI)
24.63%
28.31%
-15.29%
Gross Profit Margin
22.77%
27.01%
-18.15%
PAT Margin
12.91%
17.09%
-24.01%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -8.96% vs 360.25% in Mar 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -13.79% vs 589.86% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -14.39% vs 1,209.22% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -6.68% vs 391.01% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Molbio Diagnosti With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
408.38
736.00
-327.62
-44.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
408.38
736.00
-327.62
-44.51%
Raw Material Cost
131.47
178.20
-46.73
-26.22%
Purchase of Finished goods
6.26
0.00
6.26
(Increase) / Decrease In Stocks
11.95
-4.80
16.75
348.96%
Employee Cost
45.92
259.10
-213.18
-82.28%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
112.19
212.70
-100.51
-47.25%
Total Expenditure (Excl Depreciation)
307.79
645.20
-337.41
-52.30%
Operating Profit (PBDIT) excl Other Income
100.59
90.80
9.79
10.78%
Other Income
3.10
25.30
-22.20
-87.75%
Operating Profit (PBDIT)
103.69
116.10
-12.41
-10.69%
Interest
10.70
9.60
1.10
11.46%
Exceptional Items
0.00
-13.50
13.50
100.00%
Gross Profit (PBDT)
92.99
93.00
-0.01
-0.01%
Depreciation
17.08
112.20
-95.12
-84.78%
Profit Before Tax
75.91
-19.20
95.11
495.36%
Tax
23.17
-10.20
33.37
327.16%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
52.74
-9.00
61.74
686.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
52.74
-9.00
61.74
686.00%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-6.00
0.00
-6.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
58.75
-9.00
67.75
752.78%
Equity Capital
11.28
403.70
-392.42
-97.21%
Face Value
1.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.21
-0.22
5.43
2,468.18%
Diluted Earnings per share
5.21
-0.22
5.43
2,468.18%
Operating Profit Margin (Excl OI)
24.63%
12.34%
0.00
12.29%
Gross Profit Margin
22.77%
12.64%
0.00
10.13%
PAT Margin
12.91%
-1.22%
0.00
14.13%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 399.38 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -8.96% vs 360.25% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 318.99%

Quarterly - Standalone Net Profit
Standalone Net Profit 56.63 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -13.79% vs 589.86% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 522.30%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.64 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -14.39% vs 1,209.22% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1,049.64%

Quarterly - Interest
Interest 8.66 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -6.68% vs 391.01% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 358.20%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.95%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading